< ?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags">
Consisting of a live and interactive presentation by Jerrold Canakis, MD, from Atlantic General Hospital and Mark H. Flasar, MD, MS, from the University of Maryland Medical Center, as well as a question-and-answer session, the program will be held at Atlantic General Hospital from 6-8 p.m. Register by calling 1-877-807-5271 or emailing email@example.com.
Crohn’s disease and ulcerative colitis are chronic digestive disorders of the intestines. These illnesses are collectively known as inflammatory bowel diseases, or IBD, because many of their symptoms and complications are similar. It is estimated that some 1.4 million Americans suffer from IBD, with approximately 30,000 new cases diagnosed each year.
Topics of discussion will include:
· Overview of inflammatory bowel diseases
· Recognition of symptoms and importance of diagnosis
· Review of current therapies and emerging research
· Management of disease and emotional wellness and resources
This educational program is being provided in part by an educational grant from
Shire PLC and Salix Pharmaceuticals Inc., with no cost to attendees.
The Crohn’s & Colitis Foundation of America’s mission is to cure Crohn’s disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases.
The Foundation ranks third among leading health nonprofits in the percentage of expense devoted to research toward a cure, with more than 81 cents of every dollar the Foundation spends going to mission-critical programs.
The Foundation consistently meets the standards of organizations that monitor charities, including the Better Business Bureau’s Wise Giving Alliance (www.give.org) and the American Institute of Philanthropy (www.charitywatch.org). For information, contact the Foundation at 800-932-2423 or visit www.ccfa.org.
Canakis, a board-certified gastroenterologist at